Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy

Human Mutation

Volumn 28, Issue 10, 2007, Pages 950-957

  Li, Gui Sen ^a,b,c   Zhu, Li ^a,b,c   Zhang, Hong ^a,b,c   Lv, Ji Cheng ^a,b,c   Ding, Jia Xiang ^a,b,c   Zhao, Ming Hui ^a,b,c   Shen, Yan ^d   Wang, Hai Yan ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Haplotype; IgA nephropathy; Promoter; Sialic acid; ST6GALNAC2

Indexed keywords

LUCIFERASE; SIALIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; NEU1 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ST6GALNAC2 GENE;

ADOLESCENT; ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SIALYLTRANSFERASES; TRANSCRIPTION, GENETIC;

EID: 34948884533     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20543     Document Type: Article

References (48)

1. Allen AC. 1995. Abnormal glycosylation of IgA: is it related to the pathogenesis of IgA nephropathy? Nephrol Dial Transplant 10:1121-1124.
2. Allen AC, Harper SJ, Feehally J. 1995. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470-474.
3. Barratt J, Feehally J. 2005. IgA nephropathy. J Am Soc Nephrol 16:2088-2097.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Basset C, Devauchelle V, Durand V, Jamin C, Pennec YL, Youinou P, Dueymes M. 1999. Glycosylation of immunoglobulin A influences its receptor binding. Scand J Immunol 50:572-579.
6. Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S. 2006. Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst 98:911-919.
7. Chow KM, Wong TY, Li PK. 2005. Genetics of common progressive renal disease. Kidney Int Suppl 94:S41-S45.
8. Coppo R, Amore A. 2004. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544-1547.
9. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12.
10. den Dunnen JT, Paalman MH. 2003. Standardizing mutation nomenclature: why bother? Hum Mutat 22:181-182.
11. Ding K, Zhang J, Zhou K, Shen Y, Zhang X. 2005a. htSNPer1.0: software for haplotype block partition and htSNPs selection. BMC Bioinformatics 6:38.
12. Ding K, Zhou K, Zhang J, Knight J, Zhang X, Shen Y. 2005b. The effect of haplotype-block definitions on inference of haplotype-block structure and htSNPs selection. Mol Biol Evol 22:148-159.
13. Doerge RW, Churchill GA. 1996. Permutation tests for multiple loci affecting a quantitative character. Genetics 142:285-294.
14. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8:186-194.
15. Ewing B, Hillier L, Wendl MC, Green P. 1998. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175-185.
16. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M, Barnes PF, Selman M, Granados J. 2005. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 202:1649-1658.
17. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, Cooper K, Amoroso A, Viola BF, Battini G, Caridi G, Canova C, Farhi A, Subramanian V, Nelson-Williams C, Woodford S, Julian BA, Wyatt RJ, Lifton RP. 2000. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26:354-357.
18. Gordon D, Abajian C, Green P. 1998. Consed: a graphical tool for sequence finishing. Genome Res 8:195-202.
19. Gordon D, Finch SJ. 2005. Factors affecting statistical power in the detection of genetic association. J Clin Invest 115:1408-1418.
20. Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y. 1998. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol 9:577-582.
21. Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC, Buckland PR. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Hum Mutat 24:35-42.
22. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. 2000. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57:1818-1835.
23. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. 2003. Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567-571.
24. Iwase H, Tanaka A, Hiki Y, Kokubo T, Sano T, Ishii-Karakasa I, Toma K, Kobayashi Y, Hotta K. 1999. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J Chromatogr B Biomed Sci Appl 724:1-7.
25. Izzi C, Sanna-Cherchi S, Prati E, Belleri R, Remedio A, Tardanico R, Foramitti M, Guerini S, Viola BF, Movilli E, Beerman I, Lifton R, Leone L, Gharavi A, Scolari F. 2006. Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int 69:1033-1040.
26. Knudsen TB, Kristiansen TB, Katzenstein TL, Eugen-Olsen J. 2001. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression. J Med Virol 65:441-444.
27. Kokubo T, Hiki Y, Iwase H, Tanaka A, Toma K, Hotta K, Kobayashi Y. 1998. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 9:2048-2054.
28. Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y. 2000. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 15:28-33.
29. Kwok JB, Teber ET, Loy C, Hallupp M, Nicholson G, Mellick GD, Buchanan DD, Silhurn PA, Schofield PR. 2004. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 55:329-334.
30. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. 2003. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55:56-65.
31. Levey A, Greene T, Kusek J, Beck G, Group M. 2000. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:828A.
32. Levy M, Berger J. 1988. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 12:340-347.
33. Marcos NT, Pinho S, Grandela C, Cruz A, Samyn-Petit B, Harduin-Lepers A, Almeida R, Silva F, Morais V, Costa J, Kihlberg J, Clausen H, Reis CA. 2004. Role of the human SToGalNAc-I and SToGalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res 64:7050-7057.
34. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
35. Pshezhetsky AV, Richard C, Michaud L, Igdoura S, Wang S, Elsliger MA, Qu J, Leclerc D, Gravel R, Dallaire L, Potier M. 1997. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet 15:316-320.
36. Raska M, Moldoveanu Z, Andrasi J, Brown R, Hall S, Kulhavy R, Tomana M, Julian BA, Novak J, Mestecky J. 2004. Identification of a candidate gene for CMP-NeuAc:GalNac-IgA1 α 2,6-sialyltransferase in an IgA1-producing cell line. 10th International Symposium on IgA Nephropathy. Saint-Etienne, France. March 26-27, 2004. The International IgA Nephropathy Network (II, ANN). [Abstract].
37. Samyn-Petit B, Krzewinski-Recchi MA, Steelant WF, Delannoy P, Harduin-Lepers A. 2000. Molecular cloning and functional expression of human SToGalNAc II. Molecular expression in various human cultured cells. Biochim Biophys Acta 1474:201-211.
38. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
39. Scolari F. 1999. Familial IgA nephropathy. J Nephrol 12:213-219.
40. Scolari F. 2003. Inherited forms of IgA nephropathy. J Nephrol 16:317-320.
41. Seyrantepe V, Poupetova H, Froissart R, Zabot MT, Maire I, Pshezhetsky AV. 2003. Molecular pathology of NEU1 gene in sialidosis. Hum Mutat 22:343-352.
42. Smith AC, Feehally J. 2003. New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy. Springer Semin Immunopathol 24:477-493.
43. Sun T, Zhou Y, Li H, Han X, Shi Y, Wang L, Miao X, Tan W, Zhao D, Zhang X, Guo Y, Lin D. 2005. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med 202:967-974.
44. Tabor HK, Risch NJ, Myers RM. 2002. Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3:391-397.
45. Takei T, Iida A, Nitta K, Tanaka T, Ohnishi Y, Yamada R, Maeda S, Tsunoda T, Takeoka S, Ito K, Honda K, Uchida K, Tsuchiya K, Suzuki Y, Fujioka T, Ujiie T, Nagane Y, Miyano S, Narita I, Gejyo F, Nihei H, Nakamura Y. 2002. Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet 70:781-786.
46. Traving C, Schauer R. 1998. Structure, function and metabolism of sialic acids. Cell Mol Life Sci 54:1330-1349.
47. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. 2004. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168-175.
48. Xu LX, Zhao MH. 2005. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 68:167-172.